Submitted by Anonymous (not verified) on 28 January 2026 - 15:10
Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised